rhenium has been researched along with Vulvar Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrozzo, AM; Cipriani, C; Donati, P; Muscardin, L; Sedda, AF | 1 |
| Bourkoula, A; Livaniou, E; Papadopoulos, A; Papadopoulos, M; Paravatou-Petsotas, M; Pelecanou, M; Pietzsch, HJ; Pirmettis, I; Santos, I | 1 |
1 trial(s) available for rhenium and Vulvar Neoplasms
| Article | Year |
|---|---|
Dermo Beta Brachytherapy with 188Re in extramammary Paget's disease.
Topics: Aged; Brachytherapy; Female; Humans; Male; Middle Aged; Paget Disease, Extramammary; Penile Neoplasms; Radioisotopes; Rhenium; Urinary Bladder Neoplasms; Vulvar Neoplasms | 2014 |
1 other study(ies) available for rhenium and Vulvar Neoplasms
| Article | Year |
|---|---|
Synthesis and characterization of rhenium and technetium-99m tricarbonyl complexes bearing the 4-[3-bromophenyl]quinazoline moiety as a biomarker for EGFR-TK imaging.
Topics: Animals; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Female; Humans; Magnetic Resonance Spectroscopy; Male; Mice; Organotechnetium Compounds; Phosphorylation; Quinazolines; Rhenium; Vulvar Neoplasms | 2009 |